EXPERT: FDA ISN'T LIKELY TO WITHDRAW PART 11

Drug GMP Report
KEYWORDS FDA / Part 11
A A

Despite cries from some industry groups to kill 21 CFR Part 11, the FDA isn’t likely to take such a drastic step, according to a former FDA policymaker.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $10.00